Abstract:Abstract Introduction: Over the past thirty years, esophageal cancer (EC) incidence has been increasing more rapidly than any other solid neoplasm in the Western world. Globally, there is a large male predominance in both esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC). The reasons for this gender difference and the possible role of estrogen remains unclear. We conducted an analytical epidemiological study to determine if estrogen exposure explains the male predominance in observed esophageal cancer incidence. Materials/Methods: We evaluated the Surveillance Epidemiology and End Results (SEER) cancer incidence trends from 1975 to 2008 using SEER Stat to calculate the annual percentage change (APC) in each five year age group and in EAC and ESCC by gender. Results: Male predominance in incidence rates of EC was most evident in the younger population and those with EAC histology as previously demonstrated. EAC and ESCC incidence rates both increases with aging, consistent with cancer being an age-related disease, but the male: female incidence ratio of EAC significantly decreased with aging. The rate of increase for EAC incidence in post menopausal females is greater than in any other demographic category. This increasing incidence rate in the post menopausal female was also observed in the ESCC, but to a lesser extent. The APC was negative (-1.5) between 1975-2008 only in the 50-64 age female cohort. Interestingly, the APC doubled in the last two age groupings of older females (age 65-74 = + 0.3 and age 75 and greater = + 0.7). APC rates for the males increased gradually in all their age groups (age 50-64 = +1.2, age 65-74 = +1.4, age 75+ = +1.9). Conclusions: The males’ incidence of EAC increases at a steep rate with aging and females’ incidence rates are not as steep except after age 60-64 where their incidence rate of change steeply increases. The steeper change in EAC incidence rates in the post menopausal female may explain why the male: female EAC incidence ratio decreases with age as seen nationally (SEER). The negative APC in the female 50-64 years age group may be explained by their peri-menopausal state and by the increased use of post-menopausal hormonal therapy since 1975 for this age group. Using age as a proxy for estrogen exposure, our findings suggest a hormonal component for the observed age-related, declining male to female EAC incidence rate ratios. It also confirms gender differences in incidence long observed in EC and suggests that the pre-menopausal estrogen milieu in females may serve as a protective factor against EAC. Moreover, this protective state dissipates with time in the post menopausal females where the effect of estrogen exposure dissipates. Implications: Our initial epidemiological observation of gender-age differences warrants translation into a molecular epidemiology study with the use of sophisticated biomarkers to establish the seemingly protective role of estrogen exposure in esophageal adenocarcinoma. Citation Format: Luckson N. Mathieu, Norma Kanarek, Craig Hooker, Malcolm Brock. Gender disparity in esophageal cancer incidence. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 4802. doi:10.1158/1538-7445.AM2013-4802

Global and national trends in the age‐specific sex ratio of esophageal cancer and gastric cancer by subtype

Sex disparities in cancer incidence in Jiashan County, China, 1995-2014.

Global trends in the incidence and mortality of esophageal cancer from 1990 to 2017

Sex difference in incidence of gastric cancer: an international comparative study based on the Global Burden of Disease Study 2017.

Global Burden, Risk Factors, and Trends of Esophageal Cancer: An Analysis of Cancer Registries from 48 Countries

Global trends in the burden of esophageal cancer, 1990-2019: results from the Global Burden of Disease Study 2019

Patterns and trends in esophageal cancer incidence and mortality in China: An analysis based on cancer registry data

Abstract 4802: Gender disparity in esophageal cancer incidence.

Global changing trends in incidence and mortality of gastric cancer by age and sex, 1990-2019: Findings from Global Burden of Disease Study

IDDF2024-ABS-0428 Global Incidence of Cardia and Non-Cardia Gastric Cancer: a Population-Based Study

Incidence and Mortality Trends in Gastric Cancer in the United States, 1992-2019.

Trends in the incidence and survival of patients with esophageal cancer: A SEER database analysis

Global Incidence and Mortality of Gastric Cancer, 1980-2018

Time Trends of Esophageal and Gastric Cancer Mortality in China, 1991–2009: an Age-Period-cohort Analysis

IDDF2024-ABS-0424 Global Incidence of Oesophageal Cancer by Histological and Anatomical Subtypes: a Systematic Analysis

Gender and Age Differences in Risk Factors of Lymph Node Metastasis in Patients With Early Gastric Cancer and Analysis Prognosis of Early Gastric Cancer

Longitudinal Trends of Stomach Cancer and Esophageal Cancer in Yangzhong County: A High-Incidence Rural Area of China

Esophageal cancer: trends in incidence and mortality in China from 2005 to 2015